References
- TorénKBakeBOlinACMeasures of bronchodilator response of FEV1, FVC and SVC in a Swedish general population sample aged 50–64 years, the SCAPIS Pilot StudyInt J Chron Obstruct Pulmon Dis20171297398028356729
- VogelmeierCFCrinerGJMartinezFJGlobal Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive SummaryAm J Respir Crit Care Med2017195555758228128970
- JohannessenALehmannSOmenaasEREideGEBakkePSGulsvikAPost-bronchodilator spirometry reference values in adults and implications for disease managementAm J Respir Crit Care Med2006173121316132516556696
- Pérez-PadillaRTorre BouscouletLVázquez-GarciaJCgrupo PLATINOValores de referencia para la espirometría después de la inhalación de 200 μg de salbutamol [Spirometry reference values after inhalation of 200 microg of salbutamol]Arch Bronconeumol20074310530534 Spanish [with English abstract]17939906
- Ben SaadHPréfautCTabkaZZbidiAHayotMThe forgotten message from gold: FVC is a primary clinical outcome measure of bronchodilator reversibility in COPDPulm Pharmacol Ther200821576777318555715